Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
March 7th 2021
Letter: BPH guidelines may ignore FDA, insurance criteria
May 12th 2020

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer

PROTEUS Substudy: Perioperative apalutamide plus ADT improves EFS vs surgery alone

In situ immunotherapy shows encouraging survival findings in prostate cancer

VOLGA: Durvalumab plus enfortumab vedotin improves EFS, OS in MIBC

How should ctDNA guide adjuvant therapy after perioperative EV?